Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-01-07Clinical Trial Update: Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression
Clinical trial update describing a study at Xiangya Hospital evaluating urinary proteomic biomarkers to distinguish ovarian malignancy and t…
-
FDA label_change · 2025-01-03FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for doxorubicin hydrochloride from Zydus Lifesciences Limited, updating the labeling for the product…
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer [Phase 2]
This is a completed Phase 2 clinical trial evaluating bevacizumab in combination with tocotrienol for recurrent ovarian cancer.
-
CLINICAL_TRIALS withdrawal · 2025-01-01Clinical Trial Update: Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating neoadjuvant chemotherapy with or without HCW9218 for metastatic advanced ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update for JSKN003 in platinum-resistant, relapsed epithelial ovarian cancer; the study is currently not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations [Phase 1]
Phase I clinical trials are evaluating Axitinib for potential efficacy in patients with BRCA1/2 mutations, including breast and ovarian canc…
-
CLINICAL_TRIALS other · 2024-12-30Clinical Trial Update: Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
Agenus has launched an Expanded Access Program to provide Botensilimab and Balstilimab to patients before regulatory approval. The program t…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating CM24 in combination with nivolumab in adults with advanced…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Patient Preferences for Precision Medicine: Determining Optimal Patient Quality of Life Using PARPi's [NA]
A University of Saskatchewan study is investigating patient preferences and quality of life in precision medicine for ovarian cancer using P…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Oral AMXT 1501 Dicaprate in Combination With IV DFMO [Phase 1, Phase 2]
A Phase 1/2 trial of oral AMXT 1501 dicaprate in combination with IV DFMO has been terminated.
-
FDA approval · 2024-12-19FDA Approved: CYCLOPHOSPHAMIDE — Original Application (BluePoint Laboratories)
FDA approved BluePoint Laboratories' original ANDA for cyclophosphamide, establishing a generic version of the chemotherapy agent.
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors [Phase 1]
This Phase 1 clinical trial update evaluates CAR-macrophages targeting HER2-overexpressing solid tumors, sponsored by Carisma Therapeutics. …
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer [Phase 2]
A Phase 2 clinical trial of niraparib as neoadjuvant therapy for unresectable ovarian cancer is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer [Phase 2]
Phase 2 clinical trial update evaluating Caelyx (liposomal doxorubicin) given biweekly in heavily pretreated patients with relapsed ovarian …
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 trial evaluating NC410 in combination with pembrolizumab for advanced unresectable or metastatic solid tumors across mul…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluates Fluzoparib with or without Bevacizumab as neoadjuvant therapy for advanced ovarian cancer, with recruitme…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. [Phase 1]
A Phase I/Ib trial of NZV930 alone and in combination with PDR001 and/or NIR178 in patients with advanced malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib. [Phase 4]
Phase 4 real-world study assessing tolerability and quality of life for niraparib in ovarian cancer; the study has completed.
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes. [NA]
A clinical trial update describing an investigation into the tumor spectrum of germline mutations in genes associated with hereditary breast…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors [Phase 2]
Phase 2 trial of Utidelone as monotherapy for advanced solid tumors, currently not recruiting.
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Pharmacokinetic Study of Tranexamic Acid [NA]
Clinical trial update on a pharmacokinetic study of tranexamic acid in epithelial ovarian cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Comprehensive Outcomes for After Cancer Health [NA]
A clinical trial update from Pack Health indicates the study on comprehensive outcomes for after-cancer health is currently recruiting, cove…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors [Phase 2]
This clinical trials update describes a multicenter, open-label Phase IIa study to evaluate the efficacy and safety of B1962 injections in a…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Family History App in Personalized Medicine [NA]
An update on a university-sponsored clinical trial evaluating a family history app for personalized medicine; the study is currently active …
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating Avatar-Directed Chemotherapy for recurrent fallopian tube cancer, ovarian cancer, and primary peritoneal c…